In this current work in clinically confined RCC where the patients had received no previous treatment, we found increased pmTOR to demonstrate an association with tumour size and capsular invasion, suggesting that activated mTOR is directly linked to the proliferative capacity of cells within the localised tumour and with tumour invasion into the immediate surrounding tissue such as the renal capsule. The gene discussed is MTOR; the disease is renal cell carcinoma.